|
Montreal Heart Attack Readjustment Trial (M-HART) Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Montreal Heart Attack Readjustment Trial (M-HART) conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Montreal Heart Attack Readjustment Trial (M-HART) Clinical research trials and Montreal Heart Attack Readjustment Trial (M-HART) medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Montreal Heart Attack Readjustment Trial (M-HART). Montreal Heart Attack Readjustment Trial (M-HART) Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Montreal Heart Attack Readjustment Trial (M-HART) clinical trial. Participants frequently obtain the most expert healthcare available for their Montreal Heart Attack Readjustment Trial (M-HART) condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "M" Clinical Trials Conditions > Montreal Heart Attack Readjustment Trial (M-HART)  Montreal Heart Attack Readjustment Trial (M-HART)
Montreal Heart Attack Readjustment Trial (M-HART)
For Condition: Cardiovascular Diseases,Coronary Disease,Heart Diseases,Myocardial Infarction,Myocardial Ischemia
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To examine the impact of a monitoring and social support intervention upon survival of myocardial infarction patients.
Details: BACKGROUND: Despite evidence that social support and various aspects of negative affect may influence prognosis after a myocardial infarction, the impact of psychosocial supportive interventions had not been demonstrated. Further, little was known about the impact of psychosocial and/or interventions among women patients. Previous work by Nancy Frasure-Smith and colleagues suggested that a one-year post-myocardial infarction program of monthly telephone monitoring of psychological stress symptoms, coupled with home nursing visits for patients reporting high stress levels, had an impact on one-year cardiac mortality and long-term myocardial infarction recurrences among men. However, methodological difficulties prevented drawing firm conclusions. A trial which corrected for these difficulties was conducted involving 948 post-myocardial infarction patients. However, the project was too small to study enough patients to assess program impact separately for men and women. The trial was supported by Canadian sources. The NHLBI supplemented the study in order to expand the sample size from 948 patients to 1,376 ptients to allow gender analysis. DESIGN NARRATIVE: Randomized, with a multi-hospital design. At the time of discharge from the hospital following a documented myocardial infarction, patients were randomized to treatment and control groups. The control group received usual care from their physicians. In addition to usual care, treatment patients were phoned monthly and responded to a standardized index of psychological symptoms of stress. Those with high stress levels received home nursing visits to reduce their stress. Patients in both groups took part in three interviews: in the hospital, at three months, and at one year post-discharge. Interviews assessed depression, anxiety, anger, self-perceived stress, social support, medication compliance, and cardiac risk factors. Salivary cortisol, a physiological indicator of stress, was assessed on the evening following each interview. Indicators of residual myocardial infarction, ischemia, and arrhythmias were obtained from hospital charts. Outcome data were obtained from hospital charts, death certificates, and Quebec Medicare data and were blindly classified by study cardiologists.
Eligibility:
Study Type: Interventional, Educational/Counseling/Training, Placebo Control
Minimum Age/Maximum Age: 18 Years/75 Years
Genders: Both
Protocol Entry Criteria: Men and women myocardial infarction patients.
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: 76;
Study Start Date: February 1992
Record last reviewed: December 1996
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000533
Other Myocardial Infarction Studies:
1. Stem Cell Study for Patients with Heart Disease
2. Cardiovascular Disease Mortality in The NAS-NRC Twin Registry
3. Multicenter Investigation of Limitation of Infarct Size (MILIS)
4. Cardio Vascu-Grow for treatment of coronary heart disease
5. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study
Related Studies:
Other Myocardial Infarction Clinical Trials
Other Clinical Trials
Other Clinical Trials
Montreal Heart Attack Readjustment Trial (M-HART)
|
|
|
|
|
|
|
|
